| |
Scientific Point of View - |
Literature for the Theme
Die folgenden wissenschaftlichen Veröffentlichungen können für den Selbstkostenpreis von 1,50 Euro pro Literaturstelle (per Nachnahme) bei uns bestellt werden.
Bioavailable
testosterone and depressed mood in older men: the Rancho Bernardo Study.
Barrett-Connor E, Von Muhlen DG, Kritz-Silverstein D
Department of Family and Preventive Medicine, School of Medicine, University
of California, San Diego, La Jolla 92093-0607, USA.
Hormonal
and biochemical parameters in the determination of osteoporosis in elderly
men.
Center JR, Nguyen TV, Sambrook PN, Eisman JA
Bone and Mineral Research Program, Garvan Institute of Medical Research,
Sydney, New South Wales.
j.center@garvan.unsw.edu.au
Physiological
importance of dehydroepiandrosterone.
Ebeling P, Koivisto VA
Second Department of Medicine, Helsinki University Hospital, Finland.
Osteoporosis
in men. New insights into aetiology, pathogenesis, prevention and management.
Ebeling PR
Department of Diabetes and Endocrinology, Royal Melbourne Hospital, Victoria,
Australia. p.ebeling@medicine.unimelb.edu.au
Integrative Urology: A spectrum of complementary and alternative therapy.
Hirsch IH
Department of Urology, Jefferson Medical College, Philadelphia, Pennsylvania.
Effects of transdermal testosterone on bone and muscle in older men with
low bioavailable testosterone levels
Kenny AM, Prestwood KM, Gruman CA, Marcello KM, Raisz LG
Center of Aging and Lowell P. Weicker General Clinical Research Center,
University of Connecticut Health Center, Farmington and Braceland Center
for Mental Health and Aging, Hartford, Connecticut.
Relationship
of serum sex steroid levels and bone turnover markers with bone mineral
density in men and women: a key role for bioavailable estrogen.
Khosla S, Melton LJ 3rd, Atkinson EJ, O'Fallon WM, Klee GG, Riggs
BL
Endocrine Research Unit, Mayo Clinic, Rochester, Minnesota 55905, USA.
khosla.sundeep@mayo.edu
The
influence of estrogen on growth.
Lee PA, Witchel SF
Children's Hospital of Pittsburgh, PA 15213, USA.
Bone
density and fracture risk in men.
Melton LJ 3rd, Atkinson EJ, O'Connor MK, O'Fallon WM, Riggs BL
Department of Health Sciences Research, Mayo Clinic and Mayo Foundation,
Rochester, Minnesota 55905, USA.
Andropause: A misnomer for a true clinical entity.
Morales A, Heaton JPW, Culley CC
Department of Urology, Queen's University, Canada and Department of Urology,
University of North Carolina, North Carolina.
Effect
of replacement dose of dehydroepiandrosterone in men and women of advancing
age.
Morales AJ, Nolan JJ, Nelson JC, Yen SS
Department of Reproductive Medicine, University of California School of
Medicine, La Jolla 92093-0802.
Andropause: Is it time for the geriatrician to treat it?
Morley JE
Division of Medicine/Geriatrics, St. Louis University Medical School,
St. Louis, USA.
Androgens and aging.
Morley JE
Division of Medicine/Geriatrics, St. Louis University Medical School,
St. Louis, USA.
Effect of replacement dose of dehydroepiandrosterone in men and women of
advancing age. Androgen deficiency in aging men: Role of testosterone replacement
therapy.
Morley JE, Perry HM 3rd
Department of Medicine/Geriatrics, St. Louis University School of Medicine,
St. Louis, USA.
Androgen
deficiency in aging men.
Morley JE, Perry HM 3rd
Department of Gerontology, St. Louis University Health Sciences Center,
Missouri, USA.
Dehydroepiandrosterone
in the treatment of erectile dysfunction: a prospective, double-blind, randomized,
placebo-controlled study.
Reiter WJ, Pycha A, Schatzl G, Pokorny A, Gruber DM, Huber JC, Marberger
M
Department of Urology, University of Vienna, Austria.
Perceptions
of and risk factors for andropause.
Tan RS, Philip PS
Department of Family Practice and Community Medicine, University of Texas,
Houston 77030, USA.
Ageing
of the hypothalamo-pituitary-testicular axis in men.
Vermeulen A, Kaufman JM
Department of Endocrinology, Medical Clinic, University Hospital, Ghent,
Belgium.
Androgen
deprivation therapy for prostate cancer results in significant loss of bone
density.
Wei JT, Gross M, Jaffe CA, Gravlin K, Lahaie M, Faerber GJ, Cooney
KA
Robert Wood Johnson Clinical Scholars Program, American Foundation for
Urologic Disease and Prostate Quality Enhancement Research Initiative
of the Department of Veterans Affairs, Ann Arbor, Michigan, USA.
The
analog free testosterone assay: are the results in men clinically useful?
Winters SJ, Kelley DE, Goodpaster B
Division of Endocrinology and Metabolism, Department of Medicine, University
of Pittsburgh, PA 15213, USA. Winters@med1.dept-med.pitt.edu
Testosterone
pharmacokinetics after application of an investigational transdermal system
in hypogonadal men.
Yu Z, Gupta SK, Hwang SS, Kipnes MS, Mooradian AD, Snyder PJ, Atkinson
LE
ALZA Corporation, Palo Alto, California 94303-0802, USA.
Last update 06/2001
top
of page
|